Prebiotic xylo-oligosaccharides (XOS) ameliorate non-alcoholic fatty liver disease (NAFLD)


Watch Now


In this presentation, Satu Pekkala describes research targeting  F. prausnitzii with a diet to treat NAFLD in rats. Satu also presents a study protocol for prebiotic intervention in humans and preliminary results of the effects of XOS on human fatty liver.



Get the presentation in seconds. Fill in the form opposite.


The Kidlington Centre

Oxford, OX5 2DL

United Kington

+44 1865 849 841